Bala Vellay (@radicalonc) 's Twitter Profile
Bala Vellay

@radicalonc

Radiation oncologist , NCIS

ID: 47009902

calendar_today14-06-2009 02:00:55

132 Tweet

114 Followers

339 Following

George Mikhaeel (@georgemikhaeel) 's Twitter Profile Photo

Doxurubicin increases breast cancer risk independent of age or RT! 1964 pts mFU 21.6 years. Survivors treated with >200 mg/m2 Dox had a 1.5-fold increased BC risk, cf no Dox. BC risk increased 1.18-fold per additional 100 mg/m2 Dox (Ptrend = .004). ascopubs.org/doi/10.1200/JC…

Matthias Guckenberger (@mat_guc) 's Twitter Profile Photo

Brain mets: optimal sequencing of local Tx (LT) & CNS active systemic Tx remains unkown - retrospective study of 121 pts with EGFR mut NSCLC - 45 & 76 pts treated with upfront LT vs osimertinib alone 👉 upfront LT improved OS (HR 0.37), CNS-PFS (HR 0.36) lungcancerjournal.info/article/S0169-…

PDBrown (@pdbrownonc) 's Twitter Profile Photo

METIS positive randomized trial! Met Primary Endpoint Tumor Treatment fields significantly delay time to intracranial progression novocure.com/metis-phase-3-…

METIS positive randomized trial!
Met Primary Endpoint
Tumor Treatment fields significantly delay time to intracranial progression
novocure.com/metis-phase-3-…
giuseppe Minniti (@gminniti2012) 's Twitter Profile Photo

Intetesting data... I can say one of the most important HOT TOPIC question in the management of brain mets: is combined local treatment and targeted therapies/IO more effective than systemic treatments alone?

ISRSy (@isrsy) 's Twitter Profile Photo

ANNOUNCING: The next #ISRSWebinar📣 “Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations” 🗓️ Mon, 11 April 2024, 14:00 CET 🥼 Bala Vellayappan, MBBS, FRANZCR, MCI 👉 REGISTER: isrsy.org/webinars/

Gordo Byrn (@feelthebyrn1) 's Twitter Profile Photo

Max Heart Rate Testing & The 220-AGE Formula By John Hellemans David is an experienced 68-year-old runner. On the advice of his running buddies, he finally capitulated and invested in a heart rate monitor. A week later, he came to see me in a panic, announcing that there was

Max Heart Rate Testing & The 220-AGE Formula
By <a href="/JohnHellemans/">John Hellemans</a> 

David is an experienced 68-year-old runner. On the advice of his running buddies, he finally capitulated and invested in a heart rate monitor. A week later, he came to see me in a panic, announcing that there was
Simon Lo (@simonlo21054188) 's Twitter Profile Photo

External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline - Practical Radiation Oncology ⁦ASTRO⁩ ⁦RANZCR Rad Oncology⁩ ⁦The Royal College of Radiologists⁩ ⁦ESTRO⁩ ⁦CARO-ACRO⁩ practicalradonc.org/article/S1879-…

Krishan Jethwa (@krishanjethwa) 's Twitter Profile Photo

🚨🚨RTOG 0848🚨🚨 Anatomically resectable PDAC randomized postoperatively 1st randomization: Gemcitabine +/- erlotinib 🔥2nd Randomization🔥 +/- Chemoradiation, 50.4 Gy/28 fx + cape ✅⬆️ DFS w/ ☢️ ✅N0, ⬆️DFS and OS (5y 48% vs 29%) w/ ☢️ #ASCO24 NRG Oncology

🚨🚨RTOG 0848🚨🚨

Anatomically resectable PDAC randomized postoperatively
 1st randomization:

Gemcitabine +/- erlotinib

🔥2nd Randomization🔥
+/- Chemoradiation, 50.4 Gy/28 fx + cape

✅⬆️ DFS w/ ☢️
✅N0, ⬆️DFS and OS (5y 48% vs 29%) w/ ☢️
#ASCO24 <a href="/NRGonc/">NRG Oncology</a>
Bala Vellay (@radicalonc) 's Twitter Profile Photo

Enjoying my first #EANO2024. Thrilled to share the stage with heavy hitters Prof Helen Shih and Prof Marion Smits in the Radiation Necrosis session. Thank you giuseppe Minniti for the invitation!

Enjoying my first #EANO2024. Thrilled to share the stage with heavy hitters Prof Helen Shih and Prof Marion Smits in the Radiation Necrosis session. Thank you <a href="/gminniti2012/">giuseppe Minniti</a> for the invitation!
Simon Lo (@simonlo21054188) 's Twitter Profile Photo

It’s wonderful catching up with medical school buddy/ roommate/ co-intern, mentee and friends ⁦Yong Loo Lin School of Medicine⁩ in a social visit! ⁦The hospital food is amazing there. ⁦Bala Vellay

It’s wonderful catching up with medical school buddy/ roommate/ co-intern, mentee and friends ⁦<a href="/NUSMedicine/">Yong Loo Lin School of Medicine</a>⁩ in a social visit! ⁦The hospital food is amazing there. ⁦<a href="/radicalonc/">Bala Vellay</a>⁩
PDBrown (@pdbrownonc) 's Twitter Profile Photo

SRS for Trigeminal Schwannoma · Median 13 Gy · Median vol 4 cc · LC 95% · Symptom Improve 45% · 9% ARE journals.lww.com/neurosurgery/a…

SRS for Trigeminal Schwannoma
· Median 13 Gy
· Median vol 4 cc
· LC 95%
· Symptom Improve 45%
· 9% ARE
journals.lww.com/neurosurgery/a…
Daniel Gewolb, MD (@daniel_gewolb) 's Twitter Profile Photo

⭐️ Tips for distinguishing treatment change from tumor progression from my own experience and the literature ☢️ **Sorry for the long and very complicated post!** #Neurosurgery #Neurology #radres #futureradres The American Society of Neuroradiology UMiami Health System #MRI Radiopaedia.org #ENT #Medicine

⭐️ Tips for distinguishing treatment change from tumor progression from my own experience and the literature ☢️ 

**Sorry for the long and very complicated post!**

#Neurosurgery #Neurology #radres #futureradres <a href="/TheASNR/">The American Society of Neuroradiology</a> <a href="/UMiamiHealth/">UMiami Health System</a> #MRI <a href="/Radiopaedia/">Radiopaedia.org</a> #ENT #Medicine
the Radiosurgery Society (@the_rss) 's Twitter Profile Photo

Register now for the next FREE #RSSwebinar on "The Role of Metastasis-Directed Therapy for Oligometastases and Oligoprogression in Breast Cancer" on 10/9 at noon ET featuring Steven David, Rachel Glicksman and Winston Vuong; moderated by Bala Vellay. therss.org/education/webi…

Register now for the next FREE #RSSwebinar on "The Role of Metastasis-Directed Therapy for Oligometastases and Oligoprogression in Breast Cancer" on 10/9 at noon ET featuring <a href="/drspdavid/">Steven David</a>,  <a href="/r_glicksman/">Rachel Glicksman</a> and <a href="/WinstonVuong/">Winston Vuong</a>; moderated by <a href="/radicalonc/">Bala Vellay</a>.  therss.org/education/webi…